Tamsulosin tablets
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- SYNTHON BV
- Publication Date
- 2005-08-10
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1
Abstract
Description
Background of the invention
[0001] The present invention relates to pharmaceutical tablets comprising tamsulosin, unit dosage forms prepared therefrom and methods of preparing the pharmaceutical tablets.
[0002] Tamsulosin is the common name for 5-[2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxy-benzenesulfonamide of the following formula (1) .
[0003]
[0004] It is disclosed in EP 34432 and US 4731478 as a pharmaceutically active substance having alpha-adrenergic blocking activity for the treatment of cardiac insufficiency and benign prostatic hyperplasia.
[0005] The enantiomer (R)-Tamsulosin in hydrochloride form has been marketed in various countries, including the United States, for the treatment of symptoms of benign prostatic hyperplasia (also known as BPH), such as problems with urine output and frequency. The above-mentioned approved drug product is an oral capsule dosage form containing only 0.4 mg of tamsulosin hydrochloride. The capsules provide cont...